The Effects of Medical Comorbidities and Patient Demographics on Migraine Preventive Medication Selection and Treatment Outcomes (P2-15.006)

June 9, 2026Neurology

View Full Paper

Ask AI

Bookmark

Share

Key Points

The aim is to explore how comorbidities and patient demographics influence the selection of migraine preventive medications and their outcomes.
Evaluated various medical comorbidities and demographic factors in patients with migraine.
Analyzed treatment selection for migraine prevention based on identified comorbidities.
Assessed treatment outcomes linked to different preventive medications used.
Patients with specific comorbidities showed differences in medication selection.
Overall treatment outcomes varied according to demographic factors and comorbidities.

We only have this paper's title and publication details.

Investigates how comorbidities affect treatment outcomes in migraine patients, suggesting implications for better management.

To determine if comorbidities impact treatment selection and outcomes in patients with migraine.

No takes yet. Share an insight, caveat, or question.

Ihara et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Share